Get Breaking Business News headlines emailed to you daily.
Abbott Paying $450 Million for Facet Biotech Source: ABCNews Tuesday 9th March, 2010
Abbott Laboratories says it will buy Facet Biotech for about $450 million in cash, expanding the company's access to biotechnology drugs, including a potential treatment for multiple sclerosis.
